One customer — 13% of revenue (the year ended December 31, 2025)
“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”
One customer — 10% of revenue (the year ended December 31, 2025)
“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”
One customer — 10% of revenue (the year ended December 31, 2025)
“Instances where these contracts were at least 10% of our total premium revenue for the year ended December 31, 2025 were California with 10%, Texas with 13%, and Washington with 10%.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Molina Healthcare reaffirmed 2026 EPS guidance of at least $5.25 per share and projected 2027 premium of at least $45 billion, with EPS building blocks exceeding $9.50 per share. Georgia and Texas delays reduced the premium outlook from $46.5 billion.
Molina Healthcare reported third-quarter 2026 net income of $38 million and $0.73 per diluted share, while membership fell 14% and premium revenue declined 4% to $10.5 billion. It recorded a $93 million impairment tied to exiting MAPD in 2027.
Molina Healthcare, Inc. reported third quarter 2026 GAAP diluted EPS of $0.73 and adjusted diluted EPS of $0.89, and reaffirmed full-year 2026 premium revenue guidance of approximately $42 billion and adjusted EPS of at least $5.25.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Molina reaffirmed 2026 adjusted EPS guidance of at least $5.25 per share and reported preliminary 2027 adjusted EPS building blocks exceeding $9.50 per share on expected premium revenue of at least $45 billion. Third-quarter revenue and earnings declined as MCR increased, medical cost trend guidance rose, contract delays reduced expected premium, and expected embedded-earnings realization for 2027 was reduced.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Effective income tax rate | 33.5% | Three Months Ended June 30, 2026 filing | — |
| Ending Membership | 4.9M | Three Months Ended June 30, 2026 filing | — |
| G&A ratio | 6.7% | Three Months Ended June 30, 2026 filing | — |
| Marketplace MCR | 88.9% | Three Months Ended June 30, 2026 filing | — |
| MCR | 92.2% | Three Months Ended June 30, 2026 filing | — |
| Medicaid MCR | 92.7% | Three Months Ended June 30, 2026 filing | — |
| Medicare MCR | 90.7% | Three Months Ended June 30, 2026 filing | — |
| Pre-tax margin | 0.8% | Three Months Ended June 30, 2026 filing | — |
| Total MCR | 92.2% | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MOH
this stock
Molina Healthcare, Inc.
|
$11.82B | +24.8% | +11.7% | — | 5.7% |
|
UNH
Unitedhealth Group Inc
|
$354.57B | +19.9% | +11.8% | 22.6 | 1.6% |
|
CVS
CVS HEALTH Corp
|
$102.31B | +2.5% | +7.8% | 9.3 | 1.3% |
|
ELV
Elevance Health, Inc.
|
$93.81B | +23.2% | +12.5% | 18.4 | 2.4% |
|
CI
Cigna Group
|
$80.70B | +9.5% | +11.2% | 13.5 | 2.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Molina Healthcare reported third-quarter 2026 net income of $38 million and $0.73 per diluted share, while membership fell 14% and premium revenue declined 4% to $10.5 billion. It recorded a $93 million impairment tied to exiting MAPD in 2027.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MOH | +8.9% | +10.7% | +17.1% | +5.8% | +24.8% |
| SPY | -4.7% | -5.3% | -0.8% | -3.0% | +7.5% |
| vs SPY | +13.6% | +16.0% | +17.9% | +8.8% | +17.4% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
